The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ANIDULAFUNGIN (Accord Healthcare Pty Ltd)
Product name
ANIDULAFUNGIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
127 (255 working days)
Active ingredients
anidulafungin
Registration type
New generic medicine
Indication
Treatment of invasive candidiasis, including candidaemia in adult and in paediatric patients one month and older